Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,878 | 930 | 4,050 | 4,120 |
| Marketable Securities | 2,621 | 3,530 | 2,600 | 0 |
| Receivables | 454 | 0 | 300 | 140 |
| Other current assets | 0 | 17,190 | 200 | 110 |
| TOTAL | $7,122 | $21,650 | $7,150 | $4,370 |
| Non-Current Assets | ||||
| PPE Net | 1,317 | 780 | 1,000 | 200 |
| Investments And Advances | 0 | 0 | 2,020 | 0 |
| Other Non-Current Assets | 294 | 4 | 80 | 10 |
| TOTAL | $1,611 | $784 | $3,100 | $210 |
| Total Assets | $8,733 | $22,430 | $10,270 | $4,580 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 139 | 120 | 100 | 0 |
| Accounts payable and accrued liabilities | 1,482 | 220 | 210 | 270 |
| Accrued Expenses | 246 | 400 | 210 | 30 |
| Other current liabilities | 104 | 12,010 | 0 | 70 |
| TOTAL | $2,377 | $12,800 | $590 | $410 |
| Non-Current Liabilities | ||||
| Long Term Debt | 1,751 | 350 | 380 | 0 |
| TOTAL | $1,769 | $400 | $470 | $30 |
| Total Liabilities | $4,146 | $13,210 | $1,070 | $450 |
| Shareholders' Equity | ||||
| Common Shares | 24,601 | 31,810 | 14,790 | 6,840 |
| Retained earnings | -32,808 | -10 | -5,090 | -2,310 |
| Other shareholders' equity | 12,794 | -22,590 | -500 | -400 |
| TOTAL | $4,586 | $9,210 | $9,200 | $4,130 |
| Total Liabilities And Equity | $8,733 | $22,420 | $10,270 | $4,580 |